Filter articles using the following links

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

GenSight Biologics Reports Cash Position as of September 30, 2020 and Provides Operational Update

GenSight Biologics Appoints Elsy Boglioli to its Board of Directors

Cell & Gene Meeting on the Mesa – Virtual

EURETINA 2020 – Virtual

HealthTech Innovation Days (HTID®), Paris, France & Virtual Conference

Ophthalmology Futures Retina – Virtual Forum

Chardan 4th Annual Genetic Medicines Conference – Virtual

GenSight Biologics Announces Publication of Meta-Analysis Confirming that Spontaneous Recovery in LHON is rare in the Journal of Neuro-Ophthalmology

GenSight Biologics reports new analysis demonstrating statistically significant and clinically meaningful difference between visual outcomes in LUMEVOQ®-treated patients and natural history of Leber Hereditary Optic Neuropathy (LHON)